Regenerative medicine is the medical field that develops methods to regenerate, repair, or replace damaged or diseased cells, organs, or tissues. Regenerative medicine includes the generation and use of stem cells, tissue engineering and the production of artificial organs.
It is a translational discipline that uses tissue engineering and molecular biology to "replace, engineer, or regenerate human cells, tissues, or organs" to restore or establish normal function.
Through tissue engineering, the possibilities of growing tissues and organs in the laboratory to study pathophysiological processes are also included, with the aim of establishing a platform for the development of new diagnostic and therapeutic tools.
Image of mesenchymal stem cells by live transmitted microscopy
Scanning electron microscopy image of gelatin scaffold or matrix
Preclinical Development of new medicinal products
In the development of medicinal product, preclinical development is a research stage that begins before "clinical trials" (human testing), where various research tools are used to demonstrate safety and efficacy of the new product before it is employed in humans.
Tissue engineering is a scientific-technological tool to improve the effectiveness of new medicinal products, as it measures the effects of new human therapies on human tissues .
Innovation capabilities development
There are institutions with pre-existing capacities that enable the implementation of new regenerative medicine services. Many centers, such as hospitals, laboratories and clinics, have the raw materials and infrastructure that, with adequate implementation projects, can generate new technological innovation capabilities in the area of advanced therapies.
Advanced therapies encompass cellular therapies (e.g, with mesenchymal and / or hematopoietic stem cells), gene therapy, and tissue engineering..
Photo of dressing room before entering a clean room class III. Infrastructure with quality systems for the production of medicinal products.